SCHEMBL4124972

SCHEMBL4124972

COc1ccc(N(C(=O)OC(C)(C)C)c2cc(Cl)nc(N3CCOCC3)n2)cc1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ADORA2A P29274 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALOX15 P16050 1/20 0.39
GBA1 P04062 1/20 0.39
CRHR1 P34998 2/20 0.39
MAPT P10636 5/20 0.38
TP53 P04637 1/20 0.38
THRB P10828 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PIK3CA P42336 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3994283 0.86 LMNA (0.41) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL3992644 0.85 SMN1; SMN2 (0.39) KDM4EHPGDHSD17B10ADORA2AMEN1
SCHEMBL3991929 0.81 MT-CO2 (0.38) KDM4ECYP1A2CYP3A4CYP2C9TSHR
SCHEMBL244726 0.80 PIK3CA (0.40) KDM4ETSHRMEN1KMT2ATHRB
SCHEMBL31086578 0.76 MEN1 (0.40) KDM4EADORA2AMEN1KMT2AMAPT
SCHEMBL3115454 0.69 PIK3CA (0.39) KDM4ETSHRMEN1KMT2ASMN1; SMN2
SCHEMBL3328811 0.68 PIK3CA (0.43) KDM4EPIK3CAMAPK1MTOR
SCHEMBL21263157 0.67 PIK3R1 (0.46) PIK3CAMTOR
SCHEMBL17408814 0.67 PIK3CA (0.39) MEN1KMT2ASMN1; SMN2PIK3CAMAPK1
SCHEMBL3991404 0.67 MAPT (0.51) CYP1A2CYP2C19MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009066084-A1 2 -MORPHOLINOPYRIMIDINES AND THEIR USE AS PI3 KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-28 WO disclosed